Literature DB >> 24797633

Gestational protein restriction impairs insulin-regulated glucose transport mechanisms in gastrocnemius muscles of adult male offspring.

Chellakkan S Blesson1, Kunju Sathishkumar, Vijayakumar Chinnathambi, Chandrasekhar Yallampalli.   

Abstract

Type II diabetes originates from various genetic and environmental factors. Recent studies showed that an adverse uterine environment such as that caused by a gestational low-protein (LP) diet can cause insulin resistance in adult offspring. The mechanism of insulin resistance induced by gestational protein restriction is not clearly understood. Our aim was to investigate the role of insulin signaling molecules in gastrocnemius muscles of gestational LP diet-exposed male offspring to understand their role in LP-induced insulin resistance. Pregnant Wistar rats were fed a control (20% protein) or isocaloric LP (6%) diet from gestational day 4 until delivery and a normal diet after weaning. Only male offspring were used in this study. Glucose and insulin responses were assessed after a glucose tolerance test. mRNA and protein levels of molecules involved in insulin signaling were assessed at 4 months in gastrocnemius muscles. Muscles were incubated ex vivo with insulin to evaluate insulin-induced phosphorylation of insulin receptor (IR), Insulin receptor substrate-1, Akt, and AS160. LP diet-fed rats gained less weight than controls during pregnancy. Male pups from LP diet-fed mothers were smaller but exhibited catch-up growth. Plasma glucose and insulin levels were elevated in LP offspring when subjected to a glucose tolerance test; however, fasting levels were comparable. LP offspring showed increased expression of IR and AS160 in gastrocnemius muscles. Ex vivo treatment of muscles with insulin showed increased phosphorylation of IR (Tyr972) in controls, but LP rats showed higher basal phosphorylation. Phosphorylation of Insulin receptor substrate-1 (Tyr608, Tyr895, Ser307, and Ser318) and AS160 (Thr642) were defective in LP offspring. Further, glucose transporter type 4 translocation in LP offspring was also impaired. A gestational LP diet leads to insulin resistance in adult offspring by a mechanism involving inefficient insulin-induced IR, Insulin receptor substrate-1, and AS160 phosphorylation and impaired glucose transporter type 4 translocation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24797633      PMCID: PMC4098002          DOI: 10.1210/en.2014-1094

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  52 in total

Review 1.  Regulated transport of the glucose transporter GLUT4.

Authors:  Nia J Bryant; Roland Govers; David E James
Journal:  Nat Rev Mol Cell Biol       Date:  2002-04       Impact factor: 94.444

2.  Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis.

Authors:  C N Hales; M Desai; S E Ozanne; N J Crowther
Journal:  Biochem Soc Trans       Date:  1996-05       Impact factor: 5.407

3.  Gender-specific programming of insulin secretion and action.

Authors:  M C Sugden; M J Holness
Journal:  J Endocrinol       Date:  2002-12       Impact factor: 4.286

Review 4.  Glucose transport and glucose transporters in muscle and their metabolic regulation.

Authors:  A Klip; M R Pâquet
Journal:  Diabetes Care       Date:  1990-03       Impact factor: 19.112

5.  Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.

Authors:  Vincent Aguirre; Eric D Werner; Jodel Giraud; Yong Hee Lee; Steve E Shoelson; Morris F White
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

6.  Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.

Authors:  M M Meyer; K Levin; T Grimmsmann; H Beck-Nielsen; H H Klein
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

7.  Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle.

Authors:  S E Ozanne; G S Olsen; L L Hansen; K J Tingey; B T Nave; C L Wang; K Hartil; C J Petry; A J Buckley; L Mosthaf-Seedorf
Journal:  J Endocrinol       Date:  2003-05       Impact factor: 4.286

8.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.

Authors:  T A Gustafson; W He; A Craparo; C D Schaub; T J O'Neill
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

9.  Impairments in site-specific AS160 phosphorylation and effects of exercise training.

Authors:  Leslie A Consitt; Jessica Van Meter; Christopher A Newton; David N Collier; Moahad S Dar; Jørgen F P Wojtaszewski; Jonas T Treebak; Charles J Tanner; Joseph A Houmard
Journal:  Diabetes       Date:  2013-06-25       Impact factor: 9.461

10.  Diabetes in old male offspring of rat dams fed a reduced protein diet.

Authors:  C J Petry; M W Dorling; D B Pawlak; S E Ozanne; C N Hales
Journal:  Int J Exp Diabetes Res       Date:  2001
View more
  13 in total

1.  Pregnancy is a new window of susceptibility for bisphenol a exposure.

Authors:  Chellakkan Selvanesan Blesson; Chandrasekhar Yallampalli
Journal:  Endocrinology       Date:  2015-05       Impact factor: 4.736

2.  Fetal ovine skeletal and cardiac muscle transcriptomics are differentially altered by increased maternal cortisol during gestation.

Authors:  Serene Joseph; Bryan Alava; Andrew Antolic; Elaine M Richards; Charles E Wood; Maureen Keller-Wood
Journal:  Physiol Genomics       Date:  2020-03-02       Impact factor: 3.107

3.  Novel lean type 2 diabetic rat model using gestational low-protein programming.

Authors:  Chellakkan S Blesson; Amy K Schutt; Meena P Balakrishnan; Robia G Pautler; Steen E Pedersen; Poonam Sarkar; Daniel Gonzales; Gang Zhu; Juan C Marini; Shaji K Chacko; Uma Yallampalli; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2016-02-10       Impact factor: 8.661

4.  Gestational Protein Restriction Impairs Glucose Disposal in the Gastrocnemius Muscles of Female Rats.

Authors:  Chellakkan S Blesson; Vijayakumar Chinnathambi; Sathish Kumar; Chandrasekhar Yallampalli
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

5.  In utero low-protein-diet-programmed type 2 diabetes in adult offspring is mediated by sex hormones in rats†.

Authors:  Chellakkan S Blesson; Amy K Schutt; Vidyadharan A Vipin; Daren T Tanchico; Pretty R Mathew; Meena Balakrishnan; Ancizar Betancourt; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

Review 6.  Altered fetal skeletal muscle nutrient metabolism following an adverse in utero environment and the modulation of later life insulin sensitivity.

Authors:  Kristyn Dunlop; Megan Cedrone; James F Staples; Timothy R H Regnault
Journal:  Nutrients       Date:  2015-02-12       Impact factor: 5.717

Review 7.  The Programming Power of the Placenta.

Authors:  Amanda N Sferruzzi-Perri; Emily J Camm
Journal:  Front Physiol       Date:  2016-03-14       Impact factor: 4.566

Review 8.  Does skeletal muscle have an 'epi'-memory? The role of epigenetics in nutritional programming, metabolic disease, aging and exercise.

Authors:  Adam P Sharples; Claire E Stewart; Robert A Seaborne
Journal:  Aging Cell       Date:  2016-04-22       Impact factor: 9.304

9.  Sex Dependent Dysregulation of Hepatic Glucose Production in Lean Type 2 Diabetic Rats.

Authors:  Chellakkan S Blesson; Amy Schutt; Shaji Chacko; Juan C Marini; Pretty Rose Mathew; Daren Tanchico; Meena Balakrishnan; Chandra Yallampalli
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

10.  Prenatal Testosterone Exposure Leads to Gonadal Hormone-Dependent Hyperinsulinemia and Gonadal Hormone-Independent Glucose Intolerance in Adult Male Rat Offspring.

Authors:  Amar S More; Jay S Mishra; Kathirvel Gopalakrishnan; Chellakkan S Blesson; Gary D Hankins; Kunju Sathishkumar
Journal:  Biol Reprod       Date:  2015-11-19       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.